Inari Medical Inc (NARI) - News Archive

Breaking News: Stryker Acquires Inari Medical, Enhances VTE Solutions PortfolioPortage, Michigan, Feb. 19, 2025 — In a strategic maneuver aimed at expanding its foothold in the rapidly growing venous thromboembolism (VT...

In a significant development within the medical sector, Stryker Corporation (NYSE: SYK) has initiated a cash tender offer for all shares of Inari Medical, Inc. (NASDAQ: NARI), valuing each share at $80.00. This announce...

Stryker Announces Definitive Agreement to Acquire Inari Medical, Inc. Providing Entry into High-Growth Peripheral Vascular SegmentIn a significant development for the medical technology industry, Stryker Corporation (NY...

In the evolving landscape of thrombosis management, new collaborations and technological advancements are pivotal in enhancing patient outcomes. On October 15, 2024, Inari Medical, Inc. a medical device company committe...

Shareholder Alert: Inari Medical Faces Class Action Lawsuit Amid Investor Concerns By In a noteworthy development that is sending ripples throughout the biotech investment community, Pomerantz LLP has announced the fili...

Inari Medical Inc., a leading medical technology company focused on developing groundbreaking devices for the treatment of vascular diseases, has been hit with a class action securities lawsuit. The legal action was bro...

Inari Medical Faces Class Action Amid Impressive Revenue Performance May 28, 2024 New York Inari Medical, Inc. (NASDAQ: NARI) is facing a class action lawsuit, filed by Pomerantz LLP, which has recently garnered signifi...

Boston-based law firm Block & Leviton has announced its probe into potential securities law infringements by Inari Medical, Inc. (NASDAQ: NARI). The investigation was prompted by certain discrepancies that have caused i...

Inari Medical, the leading innovator in medical devices and therapies, has recently made strategic additions to its senior leadership team. With the appointment of Tim Benner as Senior Vice President of U.S. Sales and D...

Inari Medical Announces Impressive Results from ClotTriever CLOUT Registry; Shows Significantly Lower Rates of Post Thrombotic Syndrome than Historical Deep Vein Thrombosis TrialsInari Medical, a global leader in medica...

Inari Medical Inc, a leading innovator in the field of medical devices, recently announced the enrollment of the first patient in its groundbreaking PEERLESS II Randomized Controlled Trial (RCT). This extensive clinical...